The phenotypes of NIH 3T3 cells transfected with basic fibroblast growth factor (bFGF) cDNAs that express only the high molecular weight (HMW) forms of bFGF, the 1 8-kDa form, or all forms were examined. Cells producing the 18 kDa or all forms of bFGF were transformed at high levels of growth factor expression but were nontransformed at low levels. Cell producing low levels of HMW forms of bFGF were growth impaired when compared with the parental cells. These cells tended to form multinucleated giant cells, did not grow in soft agar, were nontumorigenic, had a normal bFGF receptor number, and had a nontransformed morphology. Cells expressing high levels of HMW bFGFs had a transformed morphology and were tumorigenic. These data suggest a specific functional role for HMWbFGF.
Introduction
Basic fibroblast growth factor (bFGF) is a low molecular weight multifunctional cytokine that has potent mitogenic and angiogenic activities (Burgess and Maciag, 1989; Rifkin and Moscatelli, 1989) . The protein was originally isolated as a 18-kDa polypeptide from bovine and human tissues (Esch et al., 1985; Moscatelli et al., 1986b) . The cloning and sequencing of the cDNAs for both human and bovine bFGF indicated that only a single ATG initiation codon was present and that the initiation of translation at this codon would yield the 18-kDa species (Abraham et al., 1986) . No additional ATG codons were found in the presumed nontranslated 5' open reading frame of either the bovine or the human bFGF cDNAs. However, the isolation of bFGFs from human placenta and guinea pig brain that contained amino acid sequences represented in the 5' open reading frame of the cDNA sequence raised the question of alternative mechanisms for generating multiple forms of bFGF in the absence of additional ATG codons (Sommer et al., 1987 Moscatelli etal., 1987) .
The mechanism used to generate these multiple forms of bFGF from a single mRNA was elucidated by Florkiewicz and Sommer (1989) and Prats et aL (1989) , who showed that initiation of translation at CUG codons located 5' to the AUG codon accounted for the bFGF species of 24, 22.5, and 22 kDa, whereas the AUG codon was used for the initiation of translation of the 18-kDa species. These workers showed that the full-length bFGF cDNA generated bFGF species of 24, 22.5, 22, and 18 kDa both in vivo and in vitro. Modification of the AUG codon resulted in the loss of the 18-kDa form, whereas the introduction of frameshift mutations 5' to the AUG codon resulted in the loss of the three higher molecular weight species of bFGF.
When the subcellular distribution of the different forms of bFGF was analyzed in SK-Hep-1 cells and NIH 3T3 cells transfected with bFGF cDNA, the 18-kDa form was found to be primarily cytosolic, whereas the three high molecular weight (HMW) forms were found predominantly-in the nuclear fraction (Renko et al., 1990; Florkiewicz et al., 1991) . The HMW forms of bFGF contain gly-arg-gly-arg-gly-arg sequences in which the arginine residues appear to be mono-and dimethylated (Burgess et aL, 1991) . The occurrence of methylarginine has been described previously for a number of proteins, several of which associate with nucleic acids (Chang et al., 1976; Boffa et al., 1977; Christensen etal., 1977) . Indeed, the amino-terminal extensions found in the HMW forms of bFGF can act as a nuclear targeting signal as chimeric proteins containing these residues fused to either chloramphenicol aminotranferase or ,B-ga-lactosidase cause the redistribution of these normally cytoplasmic enzymes into the nucleus (Bugler et al., 1991; Quarto et al., 1991) .
The formation of these unique species of bFGF with a distinct subcellular localization suggested that the nuclear forms may be functionally distinct from the 18-kDa cytosolic form. To examine this possibility, we have generated NIH 3T3 cell lines transfected with bFGF DNAs that express only the HMW forms of bFGF, the 18-kDa form, or all forms, and we have compared their phenotypes. Cells transfected with cDNAs encoding either 18 kDa or all forms of bFGF were non-transformed at low levels of bFGF expression or transformed at high levels of expression. Cells expressing only the HMW forms of bFGF, however, were growth impaired at low expression levels of these bFGF forms. The slowly growing cells also had a tendency to form multinucleated giant cells. If the cells expressed high levels of the HMW forms of bFGF, they were transformed.
Results

Transfection and cloning of cells
The 365bFGF DNA, which encoded the HMW forms of bFGF; the 43bFGF DNA, which encoded the 18-kDa form of bFGF; and the wtbFGF DNA inserted into the ZipNeoSV(X)1 vector were transfected into NIH 3T3 cells using the calcium phosphate method . After 2 wk of culture in medium containing geneticin (G418), clones were picked. At this time it was evident that although cells transfected with 43 or wtbFGF DNA grew predominantly as large colonies, cultures transfected with 365bFGF DNA tended to contain many small colonies of cells among a few larger colonies ( Figure 1A ). Cells transfected with the ZipNeoSV(X)1 vector alone had a morphology similar to that observed with the mock transfected cells (data not shown). This difference in colony types did not represent differences in transformation efficiencies as the total number of colonies obtained when NIH 3T3 cells were transfected with wt, 365, or 43bFGF plasmid DNAs were comparable (data not shown). After the selection of specific clones and regrowth, the morphology of the cells was again observed. Compared with the parental cells transfected with pZipNeoSV(X) alone, which retained a normal phenotype, some of the clones from the G418-resistant 365bFGF clones contained cells with a transformed morphology like that described previously for cells transfected with wtbFGF DNA and that expressed high levels of bFGF . These 365bFGF transfected cells were found in large colonies. However, many clones were present after G418 selection of 365bFGF cDNA transformants that appeared to grow slowly as indicated by the smaller diameters of the colonies. This was not observed in cells transfected with 43bFGF or wtbFGF cDNAs as their colonies were always large. The slowly growing clones of 365bFGF transfected cells also contained many multinucleated giant cells (Figure 1 B) . These were not seen in the clones that had a transformed morphology or in the control ZipNIH 3T3 cells.
Characterization of transfected cell clones
The state of the bFGF DNA and the levels of expression of bFGF in ZipNIH 3T3 control, wtbFGF, 43bFGF, and 365bFGF DNA transfected cells were compared. The 365bFGF clones included one (C2) that had a transformed morphology and four (C5, C6, C7, and C9) that appeared not to be transformed. The relative amounts of transfected bFGF DNA in the cells were determined by Southern blotting. Digestion of the expression vector containing the various bFGF cDNA inserts yields a single 5.8 kb Xbal restriction fragment. As can be seen in Figure 2 , 43bFGF and 365bFGF transfected cells all contained integrated specific bFGF DNA. The control cells showed no hybridization in these regions. Interestingly, the 365 clones that grew slowly (C5, C6, C7, and C9) contained less bFGF DNA than the clone with the transformed morphology (C2). Cells from C7 appeared to have an additional fragment of -4.3 kb.
The level of synthesis of bFGF in the various clones was measured qualitatively by immunoblotting using antibodies prepared against recombinant bFGF (Figure 3) . Cells from the 365bFGF clones synthesized only HMW forms of bFGF ( Figure Figure 3 , lane 6) that were also transformed. This is in agreement with our previous results indicating that a transformed phenotype in NIH 3T3 cells corresponds to high levels of bFGF expression . All of the bFGF species in clones transfected with 365bFGF ( Figure 3 , lanes 1-5) appeared to have a slightly slower mobility than the HMW species seen in the wtbFGF clone ( Figure 3 , lane 6). The reason for this difference was not investigated.
Localization of bFGF forms
We previously reported (Renko et al., 1990 ) that in wtbFGF-transfected cells the 18-kDa form of bFGF was found predominantly in the cytosol, whereas the HMW forms were found in the nucleus. To determine whether the bFGF in 365bFGF cells followed this pattern, cell fractionation and immunoblotting was performed on extracts from cells from two 365bFGF clones. Four fractions were prepared as described in Materials and methods. These were a total cell homogenate, a cytosolic fraction, a nucleoplasmic fraction, and a detergent-treated nuclear fraction. This latter fraction represented the residual insoluble material remaining after nuclei were washed with detergent. When these fractions were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and immunoblotting, it was apparent that in 365bFGF cells most of the bFGF was in the detergent-washed nuclear fraction ( Figure 4 , lanes 4 and 8). The same distribution was also seen with C2 cells (data not shown). The failure of the HMW forms of bFGF to be solubilized after detergent treatment of the nuclei implies that these proteins must be strongly associated with subnuclear structures.
Growth properties and tumorigenicity of transfected cells The growth properties of the transfected cells were examined next. Cells with a transformed morphology, whether expressing 18 kDa bFGF (43bFGF C31), high molecular weight bFGF (365bFGF C2), or all forms of bFGF (wtbFGF B3) grew to densities at least fourfold greater than the control ZipNIH 3T3 cells ( Figure 5A ). Interestingly, cells from clones C5, 6, 7, and 9 that had a low copy number of 365bFGF cDNA, little bFGF protein, and a normal morphology grew more slowly than the control ZipNIH 3T3 cells ( Figure 5B ). This result was consistent with the observation that when picked from the original plates these clones were smaller than clones composed of morphologically transformed cells.
The growth of these cells in soft agar was also checked. All of the cells with a transformed morphology (wtbFGF B3, 43bFGF C31, 365bFGF C2) grew in soft agar, whereas cells from the slow growing 365bFGF clones C5 and C6 and the control ZipNIH 3T3 cells did not (data not shown).
The tumorigenicity of cells from the 365bFGF C2, C7, and wtbFGF B3 clones, as well as ZipNIH 3T3 cells, was tested in nude mice. Within 7 d after inoculation, mice injected with morphologically transformed cells transfected with either the wtbFGF or the 365bFGF C2 constructs developed small palpable tumors (Table 1 ). These tumors did not increase in size over the next 2 wk. This result is similar to what was described earlier for several clones transfected with wtbFGF DNA high-affinity ( Figure 6 ) receptors as the ZipNIH 3T3 control cells (column 1) ( Figure 6 ). The number of receptors in clone 365C2 cells was lower than that found in the other clones and may result from the higher level of bFGF produced (data not shown). The number of lowaffinity receptors among the different clones was also equivalent (data not shown). Although the 365bFGF C5, C6, C7, and C9 cells contained normal levels of surface bFGF receptors, their growth was not stimulated when exogenous bFGF (10 ng/ml) was added to the culture medium (data not shown).
Discussion
The production of alternate forms of bFGF through the utilization of non-AUG initiation codons is a novel mechanism for the generation of growth factor diversity and has previously been described only for the cellular proteins cmyc and int-2 in addition to bFGF (Hann et al., 1988; Acland et al., 1990) residues within the HMW forms of bFGF (Burgess et al., 1991) as well as their nuclear localization suggested that these species might perform functions different from those associated with the lowest molecular weight form (18 kDa) of bFGF. As an approach to the study of the functional properties of the HMW forms of bFGF, we have established permanent cell lines that express exclusively high levels of the HMW forms of the growth factor. This was accomplished by transfection with a bFGF DNA in which the initiation codon ATG beginning at position 365 was changed to GCT, thereby eliminating the translation start site of the 18-kDa form of bFGF. When G41 8-resistant clones of NIH 3T3 cells transfected with this DNA were examined, a unique phenotype was observed (Table 1) . Many slowly growing colonies appeared. The cells within these colonies had a nontransformed morphology and many multinucleated giant cells were present. Cells from these clones grew more slowly than parental NIH 3T3 cells, did not grow in soft agar, and were non-tumorigenic. These cells contained a low copy number of bFGF DNA, produced relatively low amounts of bFGF, and appeared to have numbers of receptors equivalent to that found in control cells. It should be noted that earlier experiments (Moscatelli and Quarto, 1989) indicate that the binding of HMW guinea pig bFGF to its receptor is equivalent to that of the 1 8-kDa form. Some colonies transfected with this DNA were observed to grow rapidly, grew in soft agar, and . Thus the growthinhibiting effects of bFGF may only occur when there is an imbalance in total bFGF synthesis. It would be interesting to determine if transfection of 365bFGF clones demonstrating an altered phenotype with 43bFGF DNA would restore the normal or transformed phenotype. This could be difficult, however, because the clones have a tendency to spontaneously change their growth properties to a more rapidly growing phenotype.
Although the manner in which the expression of HMW bFGF decreases the rate of cell growth remains to be determined, our working hypothesis is that this is the result of the accumulation of this form of bFGF in the nucleus. There is no evidence to indicate that the effect of HMW bFGF is at the cell surface. The nuclear targeting sequence would ensure the rapid translocation of these proteins into the nucleus. It is possible that these forms of bFGF affect transcription by binding to specific DNA sequences. This is currently being tested. It is also possible, however, that HMW bFGFs interact with other molecules involved in cell cycle traverse and thereby decrease the rate of cell division.
Our results, combined with the observations of Couderc et al. (1991) Although the molecular mechanism for the differential effect of HMW bFGF on the cells we have studied is unknown, the presence of methylarginine residues in these forms of bFGF suggests a partial explanation. Other proteins with methylarginine have been found to be associated with nuclei acids. The unique nuclear distribution of the bFGF forms with this modification suggests that the occurrence of methylarginine residues may target the bFGF to nuclei acids. The interaction of HMW bFGF with DNA may, in part, account for the altered phenotype of these cells. It will be of interest to establish whether modifications of bFGF DNA that block the introduction of methylarginine residues yield proteins with a different distribution or with a different effect on cells. In addition, it will be of interest to establish whether the HMW forms of bFGF bind to specific nuclei acid sequences.
Materials and methods Construction of mutant bFGF cDNAs and expression vectors
The mutant bFGF cDNAs were constructed by site-direct oligonucleotide mutagenesis as described by Florkiewicz and Sommer (1989) . Briefly, the codon beginning at position 365 (365bFGF) of the wild-type bFGF cDNA was altered (ATG to GCT) using a BioRad mutagene kit (BioRad, Richmond, CA) following procedures described by the manufacturer (Machamer et al., 1985) . This mutation resulted in the inhibition of synthesis of the 1 8-kDa form of bFGF. The second mutation was a frameshift mutation at nucleotide 352 (43bFGF). Each of these mutant DNAs was sequenced to ensure that no additional changes were introduced during the mitogenesis procedure. This mutation blocked the synthesis of HMW bFGFs. The mutant cDNAs were inserted into the BamHl site of the retroviral vector pZipNeoSV(X) (Cepko et al., 1984) after methylation of the internal BamHl sites and addition of BamHl linkers (Maniatis et al., 1982; Quarto et al., 1989 2 The relative amounts of bFGF were estimated from the immunoblotting illustrated in Figure 3 and adjusted for the amount of protein used. -, undetectable; +, low (1/6 the amount found in high producers); ++, intermediate; +++, high. I The growth rates of the various clones were estimated from the illustrations in Figure 5 . +, normal growth rate; -, slower than normal; +++, more rapid than normal. Normal rate was taken to be equal to ZipNIH 3T3 control cell growth rate. 4-, normal cell morphology; +, transformed cell morphology. 5 Growth in soft agar was estimated as described by Quarto et al. (1989) . 6Tumorigenic potential was estimated as described in materials and methods. +, palpable nonprogressing tumors detected after 2-3 wk; -, no palpable tumors detected for up to 6 wk. ND, Not determined. The cells were washed once with PBS and twice with 2M NaCI-20 mM HEPES (pH 7.4) to remove '251-bFGF bound to the matrix. These fractions were used to access binding to low-affinity receptors (Moscatelli et al., 1986b (Maniatis et al., 1982) .
Immunoblotting
Cell cultures were washed twice with cold phosphate-buffered saline (PBS), scraped, resuspended in a small volume of PBS containing 0.5% SDS, boiled, and sonicated three times for 20 s. Aliquots from different clones were analyzed by immunoblotting using rabbit polyclonal anti-rbFGF antibodies as previously described 
Soft agar cloning
Soft agar growth was determined as described previously Quantitation of the relative amounts of the bFGF forms in each fraction was performed by densitometric analysis (Renko et al., 1990 ).
Determination of low-and high-affinity binding of 1251-bFGF
The high-affinity binding of '251-bFGF to transfected and control cells was determined as described by Moscatelli and Quarto (1989 
